Waleed H. Hassanein - Feb 25, 2025 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Role
President & CEO, Director
Signature
By: /s/ Gerardo Hernandez, Attorney-in-Fact
Stock symbol
TMDX
Transactions as of
Feb 25, 2025
Transactions value $
$0
Form type
4
Date filed
2/26/2025, 06:16 PM
Previous filing
Oct 17, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMDX Common Stock Award $0 +59.8K +96.98% $0.00 121K Feb 25, 2025 Direct F1
holding TMDX Common Stock 469K Feb 25, 2025 By the Waleed H. Hassanein Revocable Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMDX Stock Option (Right to Buy) Award $0 +90.2K $0.00 90.2K Feb 25, 2025 Common Stock 90.2K $73.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of 59,781 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F2 The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 25, 2025 until the option is fully vested on February 25, 2029, subject to continued service.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney